This HTML5 document contains 129 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q43163646
rdf:type
wikibase:Item
schema:description
2010 nî lūn-bûn artigo científico videnskabelig artikel scienca artikolo vitenskapelig artikkel научни чланак bài báo khoa học 2010年学术文章 บทความทางวิทยาศาสตร์ 2010年学术文章 scientific article published in February 2010 vedecký článok 2010年学术文章 мақолаи илмӣ 2010년 논문 2010年學術文章 научни чланак artikel ilmiah article scientifique bilimsel makale 2010年學術文章 2010年學術文章 מאמר מדעי наукова стаття, опублікована в лютому 2010 articolo scientifico مقالة علمية نشرت في فبراير 2010 научная статья 2010年學術文章 επιστημονικό άρθρο artikulong pang-agham scientific article published in February 2010 tudományos cikk artículu científicu espublizáu en 2010 vetenskaplig artikel teaduslik artikkel scientific article published in February 2010 article scientific naučni članak 2010年の論文 artigo científico article científic 2010年学术文章 wissenschaftlicher Artikel 2010年學術文章 tieteellinen artikkeli 2010年学术文章 научна статия wetenschappelijk artikel vitskapeleg artikkel ফেব্রুয়ারি ২০১০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ articol științific artikull shkencor artykuł naukowy 2010年学术文章 სამეცნიერო სტატია artículo científico publicado en 2010 artigo científico vědecký článek
p:P577
wds:Q43163646-B28A91C8-D94B-43D6-B18F-2B9588F75CD2
wdt:P577
2010-02-01T00:00:00Z
p:P407
wds:Q43163646-21B14DD6-AD73-4306-BCFB-AC1BD421A849
wdt:P407
wd:Q1860
p:P2093
wds:Q43163646-EB1542B2-2B2C-421E-931A-B8C3E8DA4BAB wds:Q43163646-093C5C02-FB57-48B2-9B01-91B9897F87DA wds:Q43163646-3ED1F37E-E36C-412F-9B21-178F31BFB4B0 wds:Q43163646-5CF97E4A-627F-4A6B-A731-61CABBDD74A0 wds:Q43163646-5F83253B-B179-4B8C-B8C4-DC0E956DBA32 wds:Q43163646-6A1373D9-A913-428E-9628-2ED4427AABC7
wdt:P2093
Stuart L Solomon Michael W Ball John S Douglas Charles O'Shaughnessy Peter J Fitzgerald Bernard M Reen
rdfs:label
A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial
skos:prefLabel
A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial
schema:name
A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial
p:P50
wds:Q43163646-4210D41E-0433-457E-96FC-067AE9278695 wds:Q43163646-6A01DD17-3851-4B0D-9A7C-BB68610086B4 wds:Q43163646-707AE85C-B47D-477B-90B3-5D4A5792861B wds:Q43163646-186D2997-F6EC-4244-81FA-209A6AC16946 wds:Q43163646-1F6E0FA3-26EB-4DDD-8B85-288F9532A794 wds:Q43163646-331E4023-C12C-476A-9DF5-B6E93C81C571 wds:Q43163646-07965923-56F2-4C3A-90C5-ACA34EA79A52 wds:Q43163646-08E65D1B-E64E-4886-9E8B-1CB329CA0606 wds:Q43163646-F60F2F0E-DE10-4ED8-BAFA-2375BBED17AF wds:Q43163646-FA37F8BD-FCCD-4989-A79B-622813369FAC wds:Q43163646-FD2BC9BE-D4E3-46A4-B850-A5B25D21C549 wds:Q43163646-80F6850B-C3F5-4B14-BCB0-FE3DBD53FF10 wds:Q43163646-ACBAAD51-D7F7-4BAC-93B8-2617003B763A wds:Q43163646-C3007D35-C6CA-4FF0-8920-D066E34451F1
wdt:P50
wd:Q114445149 wd:Q106722006 wd:Q114445153 wd:Q106722837 wd:Q114406348 wd:Q112156984 wd:Q90071966 wd:Q87844791 wd:Q114304285 wd:Q114304367 wd:Q114445151 wd:Q114445150 wd:Q93141120 wd:Q114445152
p:P1476
wds:Q43163646-E196CADA-DD0E-413F-85BD-28748D5ECAA5
wdt:P1476
A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial
p:P304
wds:Q43163646-75EFEC2C-605B-4E05-BF87-9C3D0306A4E5
wdt:P304
543-554
p:P31
wds:Q43163646-CF5D14EB-F91C-4957-BDE5-D147D6D657BE
wdt:P31
wd:Q13442814
p:P698
wds:Q43163646-A81B48BD-06C6-4E18-8B86-6BFBA2D1FB21
wdtn:P698
n12:20152559
wdt:P698
20152559
p:P1433
wds:Q43163646-4A1FE56F-1670-4970-81C8-2445F4C23E5F
wdt:P1433
wd:Q2984355
p:P433
wds:Q43163646-2A3B40EB-9812-45E8-9E8B-9B85E623838C
p:P478
wds:Q43163646-DAA135C9-DA88-46B0-973A-C492AB86D0D4
wdt:P433
6
wdt:P478
55
p:P356
wds:Q43163646-EAC3485B-7474-42B4-B5A4-0DFEFD258FC0
wdtn:P356
n9:J.JACC.2009.08.067
wdt:P356
10.1016/J.JACC.2009.08.067
p:P5875
wds:Q43163646-15394D4E-7E93-4C31-AE9D-60E8B371A7F8
wdt:P5875
41426965